Skip to main content
. 2022 Jan 25;12:1346. doi: 10.1038/s41598-022-05165-3

Table 2.

Clinical, imaging and CSF AD variables from the parent trial, and newly analyzed CSF vascular, inflammatory and immune markers.

Cognitive and functional tests Imaging measures CSF Aβ, Tau and P-tau 181 Vascular markers Inflammation and immune markers
ADL Deep WMHV Aβ 40 CRP IL-1α Eotaxin
ADAS-Cog13 Global WMHV Aβ 42 ICAM1 IL-1β Eotaxin-3
CDR-SOB Entorhinal GMV P-tau 181 SAA IL-2 IP-10
Memory composite Hippocampal GMV T-tau VCAM-1 IL-5 MCP-1
Temporal-parietal GMV meta-ROI Aβ 42/40 ratio BFGF IL-6 MCP-4
Aβ 42/T-tau FLT-1 IL-7 MDC
PIGF IL-8 MIP-1α
Tie-2 IL-10 MIP-1β
VEGF-C IL-13 TARC
VEGF-D IL-17A IL12:IL23p40
VEGF IL-15 IFN-γ
IL-16 TNF-α
TNF-β